口蹄疫市場規模、佔有率及成長分析（按疫苗類型、動物類型、通路和地區）－2025-2032 年產業預測

2023 年口蹄疫市場規模價值 32 億美元，預計將從 2024 年的 34.8 億美元成長到 2032 年的 68.4 億美元，預測期間（2025-2032 年）的複合年成長率為 8.8%。

全球獸用疫苗市場，尤其是口蹄疫（FMD）疫苗市場，由於畜產品消費量的增加和牲畜數量的增加而經歷顯著成長。由於環境變化和全球化，牲畜傳染病和通用感染疾病的出現促使世界各國政府對牲畜和家畜實施嚴格的衛生措施。這些日益成長的擔憂反映在旨在防止可能對國家經濟造成嚴重後果的通用感染疾病爆發的法律規範中。由於對牛奶、雞蛋和肉類等產品的需求不斷成長，投資也隨之增加，因此，口蹄疫疫苗接種對於減輕潛在疫情造成的經濟損失至關重要。然而，北美和歐洲等地區透過嚴格的動物移動控制有效控制了口蹄疫疫情，並減少了疫苗接種的需求。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

口蹄疫市場規模（按疫苗類型和複合年成長率） (2025-2032)

• 市場概覽
• 常規疫苗
  • 氫氧化鋁和皂素疫苗
  • 石油基疫苗
• 緊急疫苗

口蹄疫市場規模（按動物類型和複合年成長率）（2025-2032）

• 市場概覽
• 牛
• 綿羊和山羊
• 豬
• 其他動物

FMD 市場規模（依分銷管道分類）及複合年成長率（2025-2032 年）

• 市場概覽
• 獸醫診所
• 政府
• 零售藥局
• 網路藥局

口蹄疫市場規模：依地區及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Boehringer Ingelheim（Germany）
• Merck Animal Health（USA）
• Zoetis（USA）
• MSD Animal Health（USA）
• Elanco Animal Health（USA）
• Ceva Sante Animale（France）
• Virbac（France）
• Indian Immunologicals Limited（India）
• Biogenesis Bago（Argentina）
• FMD Center World Reference Laboratory（UK）
• TAD Pharma GmbH（Germany）
• Vetoquinol（France）
• Phibro Animal Health Corporation（USA）
• Tiankang Bio（China）
• Ringpu Biology（China）
• CAVAC（China）
• Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna（Italy）
• Korea Animal Health Products Association（Korea）
• CZ Veterinaria（Spain）

結論和建議

FMD Disease Market size was valued at USD 3.2 billion in 2023 and is poised to grow from USD 3.48 billion in 2024 to USD 6.84 billion by 2032, growing at a CAGR of 8.8% during the forecast period (2025-2032).

The global veterinary vaccine market, particularly for Foot-and-Mouth Disease (FMD) vaccines, is witnessing significant growth driven by increased animal product consumption and rising livestock populations. The emergence of livestock and zoonotic diseases, exacerbated by environmental changes and globalization, has prompted governments worldwide to implement stringent health measures for both domestic and livestock animals. This growing concern is reflected in regulatory frameworks aimed at preventing zoonotic outbreaks, which could severely impact national economies. With rising investments due to heightened demand for products like milk, eggs, and meat, the necessity for FMD vaccinations becomes paramount to mitigate financial losses from potential outbreaks. However, regions like North America and Europe have effectively controlled FMD incidents, reducing vaccination needs through strict animal movement regulations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Fmd Disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Fmd Disease Market Segments Analysis

Global FMD Disease Market is segmented by Vaccine Type, Animal Type, Distribution Channel and region. Based on Vaccine Type, the market is segmented into Conventional vaccines and Emergency vaccines. Based on Animal Type, the market is segmented into Cattle, Sheep & goat, Pig and Other animals. Based on Distribution Channel, the market is segmented into Veterinary hospitals & clinics, Government institutions, Retail pharmacies and Online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Fmd Disease Market

The increasing demand for animal protein and dairy products significantly drives the FMD market, as foot-and-mouth disease (FMD) can lead to substantial economic losses within the livestock sector. As consumer preferences pivot towards animal-based nutrition, the necessity to maintain healthy livestock becomes crucial. Outbreaks of FMD can disrupt supply chains, result in culling, and diminish herd productivity, leading to increased urgency for effective vaccines and management strategies. Thus, addressing both FMD outbreaks and the rising demand for livestock products is essential for ensuring food security and stability in the agricultural economy, making it a pivotal factor influencing the FMD market.

Restraints in the Fmd Disease Market

The significant expense associated with FMD vaccines and diagnostic tests poses a considerable limitation on the Foot-and-Mouth Disease (FMD) market, especially in developing nations that boast substantial livestock populations. This financial burden restricts access to essential preventive measures and diagnostic tools, hindering effective management and control of the disease in regions where it is most needed. Consequently, the high costs can deter farmers and livestock owners from investing in vaccination programs, thereby increasing the vulnerability of their herds to outbreaks. As a result, the overall progress in mitigating FMD risks is adversely affected, compromising animal health and agricultural productivity.

Market Trends of the Fmd Disease Market

The FMD (Foot-and-Mouth Disease) market is witnessing a notable trend marked by a surge in demand for vaccines, primarily fueled by heightened awareness and proactive measures taken by governments in developing countries. As these nations strive to combat FMD outbreaks that threaten livestock health and agricultural productivity, investment in vaccination programs has intensified. Additionally, the rise in livestock trade and export activities amplifies the need for effective vaccination strategies, thereby driving market growth. Pharmaceutical companies are responding with innovative vaccine formulations and expanded production capacities, creating a dynamic landscape poised for substantial advancements in FMD prevention and control.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global FMD Disease Market Size by Vaccine Type & CAGR (2025-2032)

• Market Overview
• Conventional vaccines
  • Aluminium hydroxide & saponin-based vaccines
  • Oil-based vaccines
• Emergency vaccines

Global FMD Disease Market Size by Animal Type & CAGR (2025-2032)

• Market Overview
• Cattle
• Sheep & goat
• Pig
• Other animals

Global FMD Disease Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Veterinary hospitals & clinics
• Government institutions
• Retail pharmacies
• Online pharmacies

Global FMD Disease Market Size & CAGR (2025-2032)

• North America (Vaccine Type, Animal Type, Distribution Channel)
  • US
  • Canada
• Europe (Vaccine Type, Animal Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Animal Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Animal Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Animal Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogenesis Bago (Argentina)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FMD Center World Reference Laboratory (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TAD Pharma GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tiankang Bio (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ringpu Biology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CAVAC (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Korea Animal Health Products Association (Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CZ Veterinaria (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations